Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).

@article{Dvir2014OutcomesOP,
  title={Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).},
  author={Danny Dvir and Ron Waksman and Israel Moshe Barbash and Susheel K. Kodali and Lars Georg Svensson and Emin Murat Tuzcu and Ke Xu and Sa'ar Minha and Maria C Alu and Wilson Y. Szeto and Vinod H. Thourani and Raj R. Makkar and Samir R Kapadia and Lowell F Satler and John G Webb and Martin B. Leon and Augusto D. Pichard},
  journal={Journal of the American College of Cardiology},
  year={2014},
  volume={63 3},
  pages={269-79}
}
OBJECTIVES The study aimed to evaluate the impact of chronic lung disease (CLD) on outcomes of severe aortic stenosis patients across all treatment modalities. BACKGROUND Outcomes of patients with CLD undergoing transcatheter aortic valve replacement (TAVR) have not been systematically examined. METHODS All patients who underwent TAVR in the PARTNER (Placement of AoRTic TraNscathetER Valve) trial, including the continued access registry (n = 2,553; 1,108 with CLD), were evaluated according… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 25 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 63 references

Predictors of “futility” with transcutaneous aortic valve replacement therapy (TAVR): an analysis from the PARTNER randomized trial (abstr)

  • N Beohar, V Thourani, M Mack
  • J Am Coll Cardiol 2012;60:892
  • 2014
1 Excerpt

Similar Papers

Loading similar papers…